(Q33827571)

29 July 2017

1 reference

title

Genetically engineered HSV in the treatment of glioma: a review (English)

1 reference

29 July 2017

4

B Roizman

1 reference

29 July 2017

J M Markert

1

1 reference

29 July 2017

G Y Gillespie

series ordinal

2

1 reference

29 July 2017

R R Weichselbaum

series ordinal

3

1 reference

29 July 2017

R J Whitley

series ordinal

5

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Reviews in Medical Virology

29 July 2017

published in

1 reference

29 July 2017

volume

10

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

17-30

1 reference

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Present status of oncolytic virus studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

p53-dependent cell death/apoptosis is required for a productive adenovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Liposomal transfection efficiency and toxicity on glioma cell lines: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

An experimental model of retrovirus gene therapy for malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Adenovirus-mediated gene therapy of experimental gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Bystander tumoricidal effect in the treatment of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Spatial and temporal control of gene therapy using ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Transfection of C6 glioma cells with the bax gene and increased sensitivity to treatment with cytosine arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Mechanism and application of genetic recombination in herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Genetics of natural resistance to herpesvirus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Gene transfer to brain using herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Capsid assembly and DNA packaging in herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28200001%2F02%2910%3A1%3C17%3A%3AAID-RMV258%3E3.0.CO%3B2-G

10.1002/(SICI)1099-1654(200001/02)10:1<17::AID-RMV258>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference